Why the study?
The study aimed to evaluate the effect of elective percutaneous coronary revascularization on coronary flow capacity using serial stress transthoracic Doppler echocardiography.
Does elective PCI improve coronary flow capacity measured by transthoracic Doppler echocardiography in patients with chronic coronary syndrome?
Does elective PCI improve coronary flow capacity measured by transthoracic Doppler echocardiography in patients with chronic coronary syndrome?
Despite FFR improvements, elective PCI does not universally improve coronary flow capacity, suggesting preprocedural non-invasive STDE may help identify lesions that truly benefit from revascularization.
Coronary flow capacity (CFC) integrates quantitative assessment of hyperemic myocardial blood flow and coronary flow reserve. We aimed to evaluate the effect of elective percutaneous coronary revascularization (PCI) on CFC using serial stress transthoracic Doppler echocardiography (STDE). Overall, 148 stable patients underwent STDE of the left anterior descending arteries (LAD), before and after elective PCI. Coronary flow velocity reserve (CFVR) was measured using basal and hyperemic diastolic peak velocity (hDPV). Vessels were classified into four CFC categories: severely, moderately, or mildly reduced CFC, and normal flow. Changes in hDPV and CFC status post-PCI, as well as predictors of hDPV increase, were assessed. Despite improvements in fractional flow reserve (FFR) in all cases, 31 cases (20.9%) showed a decrease in hDPV following PCI. Vessels with ischemic CFC, defined as moderately or severely reduced CFC, decreased from 46.6% (69/148) to 19.6% (29/148) post-PCI. Conversely, CFC worsened in 15.5% of patients. Multivariable analysis showed lower pre-PCI hDPV and ischemic CFC were independently predictive of higher-level (> 50%) hDPV increase after PCI. Approximately 20% of FFR-guided LAD PCI resulted in decreased hDPV. CFC deterioration was not uncommon despite FFR improvement. Preprocedural non-invasive STDE may help identify lesions that benefit from revascularization.
No takes yet. Share an insight, caveat, or question.
Ueno et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: